{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T05:03:41Z","timestamp":1746680621503,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10286-023-00922-4","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T12:03:03Z","timestamp":1673870583000},"page":"51-62","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Heart rate variability and microvolt T\u00a0wave alternans changes during ajmaline test may predict prognosis in Brugada syndrome"],"prefix":"10.1007","volume":"33","author":[{"given":"Paul-Adrian","family":"C\u0103lburean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Pannone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Sorgente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana\u00efs","family":"Gauthey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antanas","family":"Strazdas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Almorad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Bisignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gezim","family":"Bala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robbert","family":"Ramak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Overeinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Str\u00f6ker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudrun","family":"Pappaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Van Dooren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomy","family":"de Ravel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"La Meir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Brugada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Sieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian-Battista","family":"Chierchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9351-0760","authenticated-orcid":false,"given":"Carlo","family":"de Asmundis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"922_CR1","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","volume":"20","author":"P Brugada","year":"1992","unstructured":"Brugada P, Brugada J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol 20:1391\u20131396","journal-title":"J Am Coll Cardiol"},{"key":"922_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","volume":"121","author":"V Probst","year":"2010","unstructured":"Probst V, Veltmann C, Eckardt L et al (2010) Long-term prognosis of patients diagnosed with Brugada syndrome. Circulation 121:635\u2013643","journal-title":"Circulation"},{"doi-asserted-by":"publisher","unstructured":"Zeppenfeld k, Tfelt-Hansen j, de Riva M et al (2022) 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 43:3997\u20134126. https:\/\/doi.org\/10.1093\/eurheartj\/ehac262","key":"922_CR3","DOI":"10.1093\/eurheartj\/ehac262"},{"key":"922_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jacc.2011.08.064","volume":"59","author":"SG Priori","year":"2012","unstructured":"Priori SG, Gasparini M, Napolitano C et al (2012) Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol 59:37\u201345","journal-title":"J Am Coll Cardiol"},{"key":"922_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.amjcard.2021.08.035","volume":"160","author":"J-J Chow","year":"2021","unstructured":"Chow J-J, Leong KMW, Yazdani M et al (2021) A multicenter external validation of a score model to predict risk of events in patients with Brugada syndrome. Am J Cardiol 160:53\u201359","journal-title":"Am J Cardiol"},{"key":"922_CR6","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.amjcard.2017.01.039","volume":"119","author":"C de Asmundis","year":"2017","unstructured":"de Asmundis C, Mugnai G, Chierchia G-B et al (2017) Long-term follow-up of probands with Brugada syndrome. Am J Cardiol 119:1392\u20131400","journal-title":"Am J Cardiol"},{"key":"922_CR7","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.hrthm.2017.04.044","volume":"14","author":"J Sieira","year":"2017","unstructured":"Sieira J, Ciconte G, Conte G et al (2017) Long-term prognosis of drug-induced Brugada syndrome. Heart Rhythm 14:1427\u20131433","journal-title":"Heart Rhythm"},{"key":"922_CR8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jacep.2021.03.010","volume":"7","author":"V Russo","year":"2021","unstructured":"Russo V, Pafundi PC, Caturano A et al (2021) Electrophysiological study prognostic value and long-term outcome in drug-induced type 1 Brugada syndrome. JACC Clin Electrophysiol 7:1264\u20131273","journal-title":"JACC Clin Electrophysiol"},{"key":"922_CR9","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.hrthm.2017.02.026","volume":"14","author":"B Gray","year":"2017","unstructured":"Gray B, Kirby A, Kabunga P, Freedman SB, Yeates L, Kanthan A, Medi C, Keech A, Semsarian C, Sy RW (2017) Twelve-lead ambulatory electrocardiographic monitoring in Brugada syndrome: potential diagnostic and prognostic implications. Heart Rhythm 14:866\u2013874","journal-title":"Heart Rhythm"},{"key":"922_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.hroo.2022.01.011","author":"JM Daw","year":"2022","unstructured":"Daw JM, Chahal CAA, Arkles JS et al (2022) Longitudinal electrocardiographic assessment in Brugada syndrome. Heart Rhythm O2. https:\/\/doi.org\/10.1016\/j.hroo.2022.01.011","journal-title":"Heart Rhythm O2"},{"key":"922_CR11","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1093\/eurheartj\/ehl205","volume":"27","author":"C Veltmann","year":"2006","unstructured":"Veltmann C, Schimpf R, Echternach C, Eckardt L, Kuschyk J, Streitner F, Spehl S, Borggrefe M, Wolpert C (2006) A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. Eur Heart J 27:2544\u20132552","journal-title":"Eur Heart J"},{"key":"922_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.020767","volume":"10","author":"F Vitali","year":"2021","unstructured":"Vitali F, Brieda A, Balla C, Pavasini R, Tonet E, Serenelli M, Ferrari R, Delise P, Rapezzi C, Bertini M (2021) Standard ECG in Brugada syndrome as a marker of prognosis: from risk stratification to pathophysiological insights. J Am Heart Assoc 10:e020767","journal-title":"J Am Heart Assoc"},{"key":"922_CR13","first-page":"1400","volume":"21","author":"A Delini\u00e8re","year":"2019","unstructured":"Delini\u00e8re A, Baranchuk A, Giai J et al (2019) Prediction of ventricular arrhythmias in patients with a spontaneous Brugada type 1 pattern: the key is in the electrocardiogram. EP Eur 21:1400\u20131409","journal-title":"EP Eur"},{"key":"922_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jelectrocard.2020.08.023","volume":"63","author":"A Delini\u00e8re","year":"2020","unstructured":"Delini\u00e8re A, Baranchuk A, Bessi\u00e8re F et al (2020) Prognostic significance of a low T\/R ratio in Brugada syndrome. J Electrocardiol 63:6\u201311","journal-title":"J Electrocardiol"},{"key":"922_CR15","doi-asserted-by":"publisher","first-page":"e008617","DOI":"10.1161\/JAHA.118.008617","volume":"7","author":"A Ueoka","year":"2018","unstructured":"Ueoka A, Morita H, Watanabe A, Morimoto Y, Kawada S, Tachibana M, Miyamoto M, Nakagawa K, Nishii N, Ito H (2018) Prognostic significance of the sodium channel blocker test in patients with Brugada syndrome. J Am Heart Assoc 7:e008617","journal-title":"J Am Heart Assoc"},{"key":"922_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024001","volume":"11","author":"L Pannone","year":"2022","unstructured":"Pannone L, Monaco C, Sorgente A et al (2022) Ajmaline-induced abnormalities in Brugada syndrome: evaluation with ECG imaging. J Am Heart Assoc 11:e024001","journal-title":"J Am Heart Assoc"},{"key":"922_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.amjcard.2020.08.024","volume":"135","author":"A Rizzo","year":"2020","unstructured":"Rizzo A, Borio G, Sieira J et al (2020) Ajmaline testing and the Brugada syndrome. Am J Cardiol 135:91\u201398","journal-title":"Am J Cardiol"},{"key":"922_CR18","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/j.hrthm.2016.05.024","volume":"13","author":"C Antzelevitch","year":"2016","unstructured":"Antzelevitch C, Yan G-X, Ackerman MJ et al (2016) J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge. Heart Rhythm 13:e295\u2013324","journal-title":"Heart Rhythm"},{"key":"922_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx119","author":"J Sieira","year":"2017","unstructured":"Sieira J, Conte G, Ciconte G et al (2017) A score model to predict risk of events in patients with Brugada syndrome. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehx119","journal-title":"Eur Heart J"},{"key":"922_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv316","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstrom-Lundqvist C, Mazzanti A et al (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehv316","journal-title":"Eur Heart J"},{"key":"922_CR21","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S1388-2457(03)00123-8","volume":"114","author":"B Kemp","year":"2003","unstructured":"Kemp B, Olivan J (2003) European data format \u2018plus\u2019 (EDF+), an EDF alike standard format for the exchange of physiological data. Clin Neurophysiol 114:1755\u20131761","journal-title":"Clin Neurophysiol"},{"key":"922_CR22","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1161\/01.CIR.101.23.e215","volume":"101","author":"AL Goldberger","year":"2000","unstructured":"Goldberger AL, Amaral LAN, Glass L, Hausdorff JM, Ivanov PCh, Mark RG, Mietus JE, Moody GB, Peng C-K, Stanley HE (2000) PhysioBank, PhysioToolkit, and PhysioNet. Circulation 101:e215\u2013e220","journal-title":"Circulation"},{"key":"922_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.cmpb.2013.07.024","volume":"113","author":"MP Tarvainen","year":"2014","unstructured":"Tarvainen MP, Niskanen J-P, Lipponen JA, Ranta-aho PO, Karjalainen PA (2014) Kubios HRV \u2013 heart rate variability analysis software. Comput Methods Programs Biomed 113:210\u2013220","journal-title":"Comput Methods Programs Biomed"},{"key":"922_CR24","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.jacc.2008.07.041","volume":"52","author":"A Bauer","year":"2008","unstructured":"Bauer A, Malik M, Schmidt G et al (2008) Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol 52:1353\u20131365","journal-title":"J Am Coll Cardiol"},{"key":"922_CR25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike H (1974) A new look at the statistical model identification. IEEE Trans Autom Control 19:716\u2013723","journal-title":"IEEE Trans Autom Control"},{"key":"922_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118432","volume":"10","author":"T Saito","year":"2015","unstructured":"Saito T, Rehmsmeier M (2015) The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. PLoS\u00a0One 10:e0118432","journal-title":"PLoS\u00a0One"},{"key":"922_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fpubh.2017.00258","volume":"5","author":"F Shaffer","year":"2017","unstructured":"Shaffer F, Ginsberg JP (2017) An overview of heart rate variability metrics and norms. Front Public Health 5:258","journal-title":"Front Public Health"},{"key":"922_CR28","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1113\/expphysiol.2010.056259","volume":"96","author":"DS Goldstein","year":"2011","unstructured":"Goldstein DS, Bentho O, Park M-Y, Sharabi Y (2011) Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes. Exp Physiol 96:1255\u20131261","journal-title":"Exp Physiol"},{"key":"922_CR29","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s11517-016-1486-9","volume":"54","author":"Q Pan","year":"2016","unstructured":"Pan Q, Zhou G, Wang R, Cai G, Yan J, Fang L, Ning G (2016) Do the deceleration\/acceleration capacities of heart rate reflect cardiac sympathetic or vagal activity? A model study. Med Biol Eng Comput 54:1921\u20131933","journal-title":"Med Biol Eng Comput"},{"key":"922_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10840-019-00687-9","volume":"60","author":"P-A C\u0103lburean","year":"2021","unstructured":"C\u0103lburean P-A, Os\u00f3rio TG, Sieira J et al (2021) High parasympathetic activity as reflected by deceleration capacity predicts atrial fibrillation recurrence after repeated catheter ablation procedure. J Interv Card Electrophysiol 60:21\u201329","journal-title":"J Interv Card Electrophysiol"},{"key":"922_CR31","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/pace.14408","volume":"44","author":"P-A C\u0103lburean","year":"2021","unstructured":"C\u0103lburean P-A, Osorio TG, Sorgente A et al (2021) High vagal tone predicts pulmonary vein reconnection after cryoballoon ablation for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 44:2075\u20132083","journal-title":"Pacing Clin Electrophysiol"},{"doi-asserted-by":"crossref","unstructured":"Fauchier L, Babuty D, Autret L, Poret P, Cosnay P, Fauchier JP (1998) Effect of flecainide on heart rate variability in subjects without coronary artery disease or congestive heart failure. Cardiovasc Drugs Ther 12:483\u2013486","key":"922_CR32","DOI":"10.1023\/A:1007710301259"},{"key":"922_CR33","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1161\/01.CIR.80.6.1571","volume":"80","author":"RJ Myerburg","year":"1989","unstructured":"Myerburg RJ, Kessler KM, Cox MM, Huikuri H, Terracall E, Interian A, Fernandez P, Castellanos A (1989) Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol. Circulation 80:1571\u20131579","journal-title":"Circulation"},{"key":"922_CR34","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0002-9149(88)91062-4","volume":"61","author":"P Alboni","year":"1988","unstructured":"Alboni P, Paparella N, Cappato R, Candini GC (1988) Direct and autonomically mediated effects of oral flecainide. Am J Cardiol 61:759\u2013763","journal-title":"Am J Cardiol"},{"key":"922_CR35","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"DS Echt","year":"1991","unstructured":"Echt DS, Liebson PR, Mitchell LB et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Engl J Med 324:781\u2013788","journal-title":"N Engl J Med"},{"key":"922_CR36","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.hrthm.2016.10.021","volume":"14","author":"D Bacic","year":"2017","unstructured":"Bacic D, Carneiro JS, Bento AA, Nearing BD, Rajamani S, Belardinelli L, Verrier RL (2017) Eleclazine, an inhibitor of the cardiac late sodium current, is superior to flecainide in suppressing catecholamine-induced ventricular tachycardia and T-wave alternans in an intact porcine model. Heart Rhythm 14:448\u2013454","journal-title":"Heart Rhythm"},{"key":"922_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jelectrocard.2003.09.018","volume":"36","author":"Q Pham","year":"2003","unstructured":"Pham Q, Quan KJ, Rosenbaum DS (2003) T-wave alternans: marker, mechanism, and methodology for predicting sudden cardiac death. J Electrocardiol 36:75\u201381","journal-title":"J Electrocardiol"},{"key":"922_CR38","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.hrthm.2005.07.020","volume":"2","author":"S Richter","year":"2005","unstructured":"Richter S, Duray G, Hohnloser SH (2005) How to analyze T-wave alternans. Heart Rhythm 2:1268\u20131271","journal-title":"Heart Rhythm"},{"key":"922_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0167-5273(98)00014-X","volume":"64","author":"M Nakamura","year":"1998","unstructured":"Nakamura M, Isobe M, Imamura H (1998) Incessant ventricular fibrillation attacks in a patient with Brugada syndrome. Int J Cardiol 64:205\u2013206","journal-title":"Int J Cardiol"},{"key":"922_CR40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.eupc.2003.11.009","volume":"6","author":"P Maury","year":"2004","unstructured":"Maury P, Couderc P, Delay M, Boveda S, Brugada J (2004) Electrical storm in Brugada syndrome successfully treated using isoprenaline. Europace 6:130\u2013133","journal-title":"Europace"},{"key":"922_CR41","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.ehj.2003.06.005","volume":"24","author":"R Krittayaphong","year":"2003","unstructured":"Krittayaphong R, Veerakul G, Nademanee K, Kangkagate C (2003) Heart rate variability in patients with Brugada syndrome in Thailand. Eur Heart J 24:1771\u20131778","journal-title":"Eur Heart J"},{"key":"922_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jjcc.2013.12.001","volume":"64","author":"T Tokuyama","year":"2014","unstructured":"Tokuyama T, Nakano Y, Awazu A et al (2014) Deterioration of the circadian variation of heart rate variability in Brugada syndrome may contribute to the pathogenesis of ventricular fibrillation. J Cardiol 64:133\u2013138","journal-title":"J Cardiol"},{"key":"922_CR43","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1161\/01.CIR.0000143160.14610.53","volume":"110","author":"DM Bloomfield","year":"2004","unstructured":"Bloomfield DM, Steinman RC, Namerow PB et al (2004) Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy. Circulation 110:1885\u20131889","journal-title":"Circulation"},{"key":"922_CR44","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00380-015-0692-y","volume":"31","author":"S Sakamoto","year":"2016","unstructured":"Sakamoto S, Takagi M, Tatsumi H, Doi A, Sugioka K, Hanatani A, Yoshiyama M (2016) Utility of T-wave alternans during night time as a predictor for ventricular fibrillation in patients with Brugada syndrome. Heart Vessels 31:947\u2013956","journal-title":"Heart Vessels"},{"key":"922_CR45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1540-8167.2008.01148.x","volume":"19","author":"T Tada","year":"2008","unstructured":"Tada T, Kusano KF, Nagase S, Banba K, Miura D, Nishii N, Watanabe A, Nakamura K, Morita H, Ohe T (2008) Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome. J Cardiovasc Electrophysiol 19:56\u201361","journal-title":"J Cardiovasc Electrophysiol"},{"key":"922_CR46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.hrthm.2021.09.032","volume":"19","author":"L Pannone","year":"2022","unstructured":"Pannone L, Monaco C, Sorgente A et al (2022) High-density epicardial mapping in Brugada syndrome: depolarization and repolarization abnormalities. Heart Rhythm 19:397\u2013404","journal-title":"Heart Rhythm"},{"key":"922_CR47","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1161\/01.CIR.99.10.1385","volume":"99","author":"JM Pastore","year":"1999","unstructured":"Pastore JM, Girouard SD, Laurita KR, Akar FG, Rosenbaum DS (1999) Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 99:1385\u20131394","journal-title":"Circulation"},{"key":"922_CR48","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.hrthm.2022.01.034","volume":"19","author":"L Pannone","year":"2022","unstructured":"Pannone L, Monaco C, Sorgente A et al (2022) SCN5A mutation in Brugada syndrome is associated with substrate severity detected by electrocardiographic imaging and high-density electroanatomic mapping. Heart Rhythm 19:945\u2013951","journal-title":"Heart Rhythm"},{"key":"922_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.amjcard.2022.07.011","volume":"181","author":"C Monaco","year":"2022","unstructured":"Monaco C, Galli A, Pannone L et al (2022) Hybrid-approach ablation in drug-refractory arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 181:45\u201354","journal-title":"Am J Cardiol"},{"key":"922_CR50","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jacc.2018.06.037","volume":"72","author":"J Brugada","year":"2018","unstructured":"Brugada J, Campuzano O, Arbelo E, Sarquella-Brugada G, Brugada R (2018) Present status of Brugada syndrome. J Am Coll Cardiol 72:1046\u20131059","journal-title":"J Am Coll Cardiol"},{"key":"922_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.atherosclerosis.2022.03.028","volume":"350","author":"P-A C\u0103lburean","year":"2022","unstructured":"C\u0103lburean P-A, Grebeni\u0219an P, Nistor I-A et al (2022) Prediction of 3-year all-cause and cardiovascular cause mortality in a prospective percutaneous coronary intervention registry: machine learning model outperforms conventional clinical risk scores. Atherosclerosis 350:33\u201340","journal-title":"Atherosclerosis"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-023-00922-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10286-023-00922-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-023-00922-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T17:15:15Z","timestamp":1677863715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10286-023-00922-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["922"],"URL":"https:\/\/doi.org\/10.1007\/s10286-023-00922-4","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"type":"print","value":"0959-9851"},{"type":"electronic","value":"1619-1560"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"20 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AB is a consultant for Biotronik. PB received compensation for teaching purposes from Biotronik. MLM is consultant for Atricure. GC received compensation for teaching purposes and proctoring from Medtronic, Abbott, Biotronik, Boston Scientific, Acutus Medical. CdA receives research grants on behalf of the center from Biotronik, Medtronic, Abbott, LivaNova, Boston Scientific, AtriCure, Philips, and Acutus; CdA received compensation for teaching purposes and proctoring from Medtronic, Abbott, Biotronik, Livanova, Boston Scientific, Atricure, Acutus Medical Daiichi Sankyo. The remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}